Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Beyond DNA repair, the immunological role of PARP-1 and its siblings.

Rosado MM, Bennici E, Novelli F, Pioli C.

Immunology. 2013 Aug;139(4):428-37. doi: 10.1111/imm.12099. Review.

2.

Poly (ADP-ribose) polymerase-1 (PARP-1) as immune regulator.

Laudisi F, Sambucci M, Pioli C.

Endocr Metab Immune Disord Drug Targets. 2011 Dec;11(4):326-33. Review.

PMID:
21476963
3.

The Role of PARP-1 in Host-Pathogen Interaction and Cellular Stress Responses.

Li H, Li Q, Li W, Xie L, Zhou M, Xie J.

Crit Rev Eukaryot Gene Expr. 2015;25(2):175-90. Review.

PMID:
26080611
4.

Poly(ADP-ribosyl)ation of FOXP3 Protein Mediated by PARP-1 Protein Regulates the Function of Regulatory T Cells.

Luo X, Nie J, Wang S, Chen Z, Chen W, Li D, Hu H, Li B.

J Biol Chem. 2015 Nov 27;290(48):28675-82. doi: 10.1074/jbc.M115.661611. Epub 2015 Oct 1. Erratum in: J Biol Chem. 2016 Jan 15;291(3):1201.

5.

Increased Foxp3+ regulatory T cells in poly(ADP-Ribose) polymerase-1 deficiency.

Nasta F, Laudisi F, Sambucci M, Rosado MM, Pioli C.

J Immunol. 2010 Apr 1;184(7):3470-7. doi: 10.4049/jimmunol.0901568. Epub 2010 Mar 5.

6.

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.

Virág L, Szabó C.

Pharmacol Rev. 2002 Sep;54(3):375-429. Review.

7.

Complex roles of members of the ADP-ribosyl transferase super family in immune defences: looking beyond PARP1.

Welsby I, Hutin D, Leo O.

Biochem Pharmacol. 2012 Jul 1;84(1):11-20. doi: 10.1016/j.bcp.2012.02.016. Epub 2012 Mar 1. Review.

PMID:
22402301
8.

Effects of PARP-1 deficiency on Th1 and Th2 cell differentiation.

Sambucci M, Laudisi F, Novelli F, Bennici E, Rosado MM, Pioli C.

ScientificWorldJournal. 2013 Nov 5;2013:375024. doi: 10.1155/2013/375024. eCollection 2013.

9.

PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

Peralta-Leal A, Rodríguez-Vargas JM, Aguilar-Quesada R, Rodríguez MI, Linares JL, de Almodóvar MR, Oliver FJ.

Free Radic Biol Med. 2009 Jul 1;47(1):13-26. doi: 10.1016/j.freeradbiomed.2009.04.008. Epub 2009 Apr 10. Review.

PMID:
19362586
10.

Interaction of PARP-2 with DNA structures mimicking DNA repair intermediates and consequences on activity of base excision repair proteins.

Kutuzov MM, Khodyreva SN, Amé JC, Ilina ES, Sukhanova MV, Schreiber V, Lavrik OI.

Biochimie. 2013 Jun;95(6):1208-15. doi: 10.1016/j.biochi.2013.01.007. Epub 2013 Jan 26.

PMID:
23357680
11.

Regulation of NFAT by poly(ADP-ribose) polymerase activity in T cells.

Valdor R, Schreiber V, Saenz L, Martínez T, Muñoz-Suano A, Dominguez-Villar M, Ramírez P, Parrilla P, Aguado E, García-Cózar F, Yélamos J.

Mol Immunol. 2008 Apr;45(7):1863-71.

PMID:
18078995
12.

A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation.

Aldinucci A, Gerlini G, Fossati S, Cipriani G, Ballerini C, Biagioli T, Pimpinelli N, Borgognoni L, Massacesi L, Moroni F, Chiarugi A.

J Immunol. 2007 Jul 1;179(1):305-12.

13.

Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation.

Erdélyi K, Bakondi E, Gergely P, Szabó C, Virág L.

Cell Mol Life Sci. 2005 Apr;62(7-8):751-9. Review.

PMID:
15868400
14.
15.

The role of poly(ADP-ribose) polymerase-1 in CNS disease.

Kauppinen TM, Swanson RA.

Neuroscience. 2007 Apr 14;145(4):1267-72. Epub 2006 Nov 2. Review.

PMID:
17084037
16.

Poly(ADP-ribosylation) and genomic stability.

Oei SL, Keil C, Ziegler M.

Biochem Cell Biol. 2005 Jun;83(3):263-9. Review.

PMID:
15959554
17.

Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.

Skaper SD.

Ann N Y Acad Sci. 2003 May;993:217-28; discussion 287-8. Review.

PMID:
12853316
18.

The emerging role of poly(ADP-ribose) polymerase-1 in longevity.

Bürkle A, Brabeck C, Diefenbach J, Beneke S.

Int J Biochem Cell Biol. 2005 May;37(5):1043-53. Epub 2004 Dec 15. Review.

PMID:
15743677
19.

Transcriptional regulation by poly(ADP-ribose) polymerase-1 during T cell activation.

Saenz L, Lozano JJ, Valdor R, Baroja-Mazo A, Ramirez P, Parrilla P, Aparicio P, Sumoy L, Yélamos J.

BMC Genomics. 2008 Apr 16;9:171. doi: 10.1186/1471-2164-9-171.

20.

Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.

Komjáti K, Besson VC, Szabó C.

Curr Drug Targets CNS Neurol Disord. 2005 Apr;4(2):179-94. Review.

PMID:
15857303

Supplemental Content

Support Center